logo-loader

Imagin Medical highlights the capabilities of its i/Blue Imaging System to detect bladder cancer

Published: 15:19 22 Oct 2020 EDT

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) CEO Jim Hutchens tells Proactive he believes the surgical imaging company can increase the efficiency and accuracy of detecting cancer, specifically bladder cancer, with its i/Blue Imaging System.

Hutchens is hosting a virtual investor event with key opinion leaders to highlight the potential of the i/Blue™ Imaging System on Thursday, October 29, 2020 at 12:00 pm EST.

Rush Rare Metals Advances Two Key Projects: Uranium in Wyoming and Niobium...

Rush Rare Metals CEO Peter Smith joined Steve Darling from Proactive to share news about the mineral exploration company's focus on its Boxi Property in Quebec and the Copper Mountain Project in Wyoming. The company recently announced the staking of the Knob claims in Wyoming, comprising 52...

15 minutes ago